Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

8.40+0.09 (+1.08%)

At close: 4:00PM EDT

8.50 +0.10 (1.19%)
After hours: 4:29PM EDT

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Triple Moving Average Crossover

View all chart patterns

Performance Outlook

Previous Close	8.31
Open	8.28
Bid	8.32 x 1200
Ask	8.59 x 800
Day's Range	8.12 - 8.64
52 Week Range	3.81 - 8.75
Volume	460,884
Avg. Volume	489,885

Market Cap	389.633M
Beta (5Y Monthly)	1.56
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Oct 31, 2014
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Research Reports

Zacks
Paratek (PRTK) Moves 14.5% Higher: Will This Strength Last?
Paratek (PRTK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Simply Wall St.
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Is Breakeven Near?
With the business potentially at an important milestone, we thought we'd take a closer look at Paratek Pharmaceuticals...
- Breakeven On The Horizon For Eguana Technologies Inc. (CVE:EGT)
  Simply Wall St.
- Motorsport Games Inc. (NASDAQ:MSGM) Is Expected To Breakeven In The Near Future
  Simply Wall St.
Motley Fool
Paratek Pharmaceuticals (PRTK) Q4 2020 Earnings Call Transcript
A press release for the company's fourth-quarter and full-year results was issued earlier today, and we've also posted slides on our website that will be referred to on this call. Participants on today's call are Evan Loh, CEO; Adam Woodrow, president and chief commercial officer; Randy Brenner, chief development and regulatory officer; Michael Bigham, executive chairman; and Sarah Higgins, vice president of finance, controller, and principal accounting officer, will also be available for questions.